 This is a randomized, controlled clinical trial at three sites to determine the safety and preliminary efficacy of the study drug to treat severe head trauma GCS 4-8. It is hypothesized that the drug may lower pressure in the brain, reduce mortality and the patient may have improved neurological function following treatment. 